Evidence map›Paper›PMID 35682596›Full record

ReviewInternational journal of molecular sciences2022

Non-Aziridination Approaches to 3-Arylaziridine-2-carboxylic Acid Derivatives and 3-Aryl-(aziridin-2-yl)ketones.

Boriss Strumfs, Kirils Velikijs, Romans Uljanovs, Stanislavs Sinkarevs, Ilze Strumfa

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Boriss StrumfsLatvian Institute of Organic Synthesis, 21 Aizkraukles Street, LV-1006 Riga, Latvia.
Kirils VelikijsDepartment of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
Romans UljanovsDepartment of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
Stanislavs SinkarevsDepartment of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
Ilze StrumfaDepartment of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia.ORCID 0000-0002-7393-9524
Riga Stradiņš University · LVLatvijas Organiskās Sintēzes Institūts · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Highly functionalized aziridines, including compounds with aromatic moieties, are attractive substrates both in synthetic and medical areas of chemistry. There is a broad and interesting set of synthetic methods for reaching these compounds. Aziridination represents the most explored tool, but there are several other more specific, less well-known, but highly promising approaches. Therefore, the current review focuses on recently described or updated ways to obtain 3-arylated aziridines via different non-aziridination-based synthetic methods, reported mainly since 2000. The presented methods belong to two main directions of synthesis, namely, cyclization of open-chain substrates and rearrangement of other heterocycles. Cyclization of open-chain substrates includes the classic Gabriel-Cromwell type cyclization of halogenated substrates with amines, base-promoted cyclization of activated aminoalcohols (or its analogues), and the oxidative cyclization of β-dicarbonyls. Rearrangements of other heterocycles are presented as the Baldwin rearrangement of 4-isoxazolines, the cycloaddition of 1.3-dipoles or dienes to 2H-azirines, and the addition of C- and N-nucleophiles to the double bond of azirines.

Indexed as

AziridinesAzirinesCarboxylic AcidsCyclizationKetonesMolecular StructureStereoisomerismAziridinesAzirinesCarboxylic AcidsKetones4-isoxazolinesaziridinesazirinesBaldwin rearrangementcyclizationcycloaddition

Identifiers

PMID35682596
PMCPMC9180376
OpenAlexW4281484950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.